Eventide Asset Management’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-150,000
| Closed | -$2.33M | – | 137 |
|
|
2017
Q2 | $2.33M | Hold |
150,000
| – | – | 0.14% | 93 |
|
|
2017
Q1 | $2.59M | Hold |
150,000
| – | – | 0.17% | 89 |
|
|
2016
Q4 | $1.65M | Hold |
150,000
| – | – | 0.11% | 98 |
|
|
2016
Q3 | $2.35M | Hold |
150,000
| – | – | 0.14% | 92 |
|
|
2016
Q2 | $1.53M | Hold |
150,000
| – | – | 0.09% | 100 |
|
|
2016
Q1 | $1.94M | Buy |
150,000
+50,000
| +50% | +$645K | 0.11% | 103 |
|
|
2015
Q4 | $2.09M | Buy |
+100,000
| New | +$2.09M | 0.1% | 99 |
|